# The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone

> **NCT02030314** · PHASE4 · WITHDRAWN · sponsor: **Virginia Commonwealth University**

## Conditions studied

- Resistant Hypertension in Kidney Transplant Patients

## Interventions

- **DRUG:** Chlorthalidone

## Key facts

- **NCT ID:** NCT02030314
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-07
- **Primary completion:** 2017-04-12
- **Final completion:** 2017-04-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The patient population changed. Unable to find patients that meet study criteria
- **Last updated:** 2017-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02030314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02030314, "The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02030314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*